Millions worldwide live with Chronic obstructive Pulmonary Disease (COPD), a progressive lung condition often dismissed as a typical smoker’s cough. [[1]] Often diagnosed in later stages, COPD considerably impacts patients’ quality of life and can lead to increased hospitalizations. [[3]] This report details the subtle signs of COPD, the key risk factors-including emerging concerns beyond conventional smoking-and the importance of early intervention for managing this increasingly prevalent condition.
Often going unnoticed in its early stages, Chronic Obstructive Pulmonary Disease (COPD) can initially be mistaken for frequent bronchitis or a persistent cough. Symptoms typically begin to appear after age 40, manifesting as a chronic cough, morning phlegm production, and shortness of breath. Everyday activities like climbing stairs or carrying groceries can become challenging. These symptoms are frequently dismissed as simply a consequence of smoking, leading to a lack of diagnosis in nearly two-thirds of cases. Recognizing the subtle signs of COPD is crucial for early intervention and improved patient outcomes, as the disease can significantly impact quality of life.
Smoking remains the primary risk factor, accounting for over 80% of cases – whether through active smoking, secondhand exposure, or even exposure in utero. However, other factors can also contribute to the development of COPD, including air pollution, occupational exposure to irritants like fumes, dust, and chemicals, childhood lung diseases, and cannabis use.
Patients experience limitations in their abilities and a decline in their quality of life.
As COPD progresses, breathing becomes increasingly difficult. Patients experience limitations in their abilities and a decline in their quality of life, and some may develop anxiety or depression. A delayed diagnosis can lead to exacerbations – sudden worsening of symptoms that may require hospitalization and accelerate respiratory decline. Early detection and management are therefore vital to slowing the disease’s progression.
Currently, there is no cure for COPD, but early and comprehensive management can slow its progression. This includes quitting smoking, regular physical activity, therapeutic education, medication, and, in some cases, oxygen therapy. Patients should understand that managing COPD often involves periods of improvement and worsening, and adapting to this reality is part of the journey.
Raising awareness, improving diagnosis, and preventing COPD are critical public health priorities. Sanofi and Regeneron are continuing research efforts to develop innovative therapeutic solutions to improve the lives of individuals living with COPD.
